At-Home Dialysis; Patients Have New Treatment Flexibility
by dialysis at home Treatment of chronic renal failure by dialysis at homeTreatment of chronic renal failure by dialysis at homeBrunner, F PThiel, G
The toxicity of Givinostat was both dose- and time-dependent, and the drug seemed to exhibit a natural selectivity for cancer cells versus healthy cells, which was maintained up to the dose of 2.5 μM and until 72 h of treatment, even if the differences were slight. However, the NHA ...
Dialysis at Sea Cruises specializes in the treatment of hemodialysis care while onboard cruise ships. Hemodialysis patients have undergone renal failure and must be dialyzed with an artificial kidney to rid the body of fluids and toxins. Dialysis at Sea Cruises provides a renal care specialist team...
Home Peritoneal Dialysis Give You Your Life Back? Stephanie Reynolds shares the pros and cons of home peritoneal dialysis. Read More Keeping Pace with Olivia's CHB Heart Disease Olivia was born with a complete heart block and needed a pacemaker. Today, Olivia is still thriving. ...
Data from the Centers for Medicare & Medicaid Services (CMS) on hospitals, nursing homes, physicians, home healthcare, dialysis, and device providers. Landing page: https://data.medicare.gov Explorer: https://data.medicare.gov/data Texas Public Use Inpatient Data File Data on 11 Million inpati...
Sampling by microdialysis is advantageous, because commercial catheters can be used, and biomarker molecules are measured in a relatively clean dialysis fluid. We envision a TNF-α monitoring strategy that combines sampling by microdialysis with BPM sensing. The fluidic system will be fully automated ...
Misha Palecek, chief development officer at DaVita Kidney Care, joins host Dr. Bob Kaiser to discuss the transition from fee-based to value-based healthcare through the lens of kidney disease. DaVita is a company that provides kidney care and dialysis services both in the U.S. and internati...
Acharya Manish said,“Various dialysis patients come to HIIMS after spending a lot of time and money in different hospitals. Our team works tirelessly to provide necessary treatment and in this way, we have treated many critical patients suffering from kidn...
Background: This study aimed to assess the efficacy, tolerance, and cost-effectiveness of roxadustat treatment for anemia in patients with chronic kidney disease not receiving dialysis (CKD ND). Methods: A meta-analysis was conducted to evaluate the clinical efficacy and tolerance of roxadustat ...